• Publications
  • Influence
Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries.
OBJECTIVE To determine the effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the vascular reactivity of uterine and cerebral arteries. DESIGN Double-blind, randomized,Expand
  • 150
  • 4
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Progetto Menopausa Italia Study Group.
OBJECTIVE To analyze determinants/risk factors for uterine prolapse in a population of women around menopause. METHODS Between 1997 and 1999, we conducted a large cross sectional study on theExpand
  • 92
  • 4
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
OBJECTIVE The objective of the study was to evaluate the prevalence of cancer and premalignant lesions in polyps on atrophic endometrium in asymptomatic postmenopausal women to compare these findingsExpand
  • 96
  • 3
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy.
OBJECTIVE To obtain data on correlates of climacteric symptoms in women around menopause attending menopause clinics in Italy. METHODS Since 1997 a large cross sectional study has been conducted onExpand
  • 58
  • 3
A Two-by-Two Factorial Trial Comparing Oral with Transdermal Estrogen Therapy and Fenretinide with Placebo on Breast Cancer Biomarkers
Purpose: Oral conjugated equine estrogen (CEE) and medroxyprogesterone acetate (MPA) increase breast cancer risk, whereas the effect of transdermal estradiol (E2) and MPA is less known. FenretinideExpand
  • 26
  • 2
Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women
Background—The increase in C-reactive protein (CRP) during oral conjugated equine estrogen (CEE) may explain the initial excess of cardiovascular disease observed in clinical studies. Because theExpand
  • 123
  • 1
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study.
BACKGROUND Postmenopausal hormone replacement therapy (HRT) relieves menopausal symptoms and may decrease mortality in recently postmenopausal women, but increases breast cancer risk. Low-doseExpand
  • 22
  • 1
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study.
OBJECTIVE To assess the value of endometrial thickness as a marker of endometrial abnormality risk during hormone therapy (HT) and to study the correlation between abnormal bleeding and abnormalExpand
  • 25
  • 1
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study.
OBJECTIVE To analyze risk factors for type 2 diabetes among women attending menopause clinics in Italy for counselling about the menopause. SUBJECTS Women attending a network of first-levelExpand
  • 24
  • 1
Chromosome Abnormalities and Yq Microdeletions in Infertile Italian Couples Referred for Assisted Reproductive Technique
This study analyses the prevalence of karyotype aberrations and Yq microdeletions in infertile couples undergoing intracytoplasmic sperm injection (ICSI). Before undergoing ICSI, each partner of 470Expand
  • 26
  • 1